April 1 (Reuters) – Regeneron Pharmaceuticals Inc and Sanofi said on Friday their experimental treatment for eczema proved highly effective in two large studies, without serious side effects often…
The post Regeneron, Sanofi eczema drug clears hurdles in big trials appeared first on NASDAQ.